Steven Woloshin, MD, MS: Challenges of False Negative COVID-19 Tests
Steven Woloshin, MD, MS, discusses a recently authored article in the New England Journal of Medicine describing the challenges and implications of false negative tests for SARS-CoV-2 infection.
Watch
Contagion Live News Network: COVID-19 Outbreak Impacts Rheumatology Research
A video review of the latest ID news.
twoXAR: Developing Novel Lupus Therapies Amid COVID 19 Research Complications
Vibeke Strand, MD, MACR, FACP, of the Division of Immunology/Rheumatology at Stanford University School of Medicine, discusses ongoing AI research in her field.
Contagion Live News Network: Should Hospitals Shorten Stays For PWID Using Outpatient Oral Antibiotics?
An overview of 3 recent infectious disease news stories.
COVID-19: Treating Lupus Amid Hydroxychloroquine Stockpiling
Vibeke Strand, MD, MACR, FACP, discusses patients who are having a hard time getting their usual supplies of HCQ.
Contagion Live News Network: Improving COVID-19 Data Collection
Given there is not a clear international standard for health records, one of the challenges in the early COVID-19 response mobilization was a delayed start to data collection and indexing.
The Value of COVID-19 Data Collection
Some countries have been proactive in patient logging and tracking. How can even retroactive assessment benefit future preventive responses?
Contagion Live News Network: FDA Revokes EUAs
A look at 3 major headlines in COVID-19 news on June 15, 2020.
Contagion Live News Network: Fauci Expresses COVID-19 Recovery Caution
Trending infectious disease news.
Contagion Live News Network: Sepsis & Norepinephrine
A brief on today's top ID stories.
Dr. Patrick Soon-Shiong: Goals of Operation Warp Speed
Patrick Soon-Shiong, MD, describes goals and expectations for the accelerated coronavirus vaccine program Operation Warp Speed.
Contagion Live News Network: Studies Support Shorter Antibiotic Duration for Uncomplicated Cystitis
A brief update on today's infectious disease news.
SARS-CoV-2 Vaccine: Does Nucleocapsid DNA Lead to Lasting Protection?
Patrick Soon-Shiong, MD, explains why an ImmunityBio SARS-CoV-2 vaccine candidate uses Nucleocapsid DNA alongside Spike DNA.
Contagion Live News Network: WHO Official Remarks on Asymptomatic Spread of SARS-CoV-2
A quick brief on today's top infectious disease news.
Has the COVID 19 Political Response Been Responsive to ID Experts?
Mary Schmidt, MD, discusses challenges in translating infectious disease advice to policy action.
Jason Pogue, PharmD: Preventing Another COVID-19 Data Disaster
Jason Pogue, PharmD, BCPS, BCIDP, speaks about the state of publishing during the COVID-19 pandemic.
Contagion Live News Network: Attenuation, Hydroxychloroquine, & More
A brief on today's top ID news.
Hydroxychloroquine & COVID 19: Is It a Clinical "Bear Market" for the Drug?
Jason Pogue, PharmD, BCPS, BCIDP, answers questions about the emerging picture for hydroxychloroquine.
Examining the PPE Supply Chain: Is Safe Manufacturing Possible?
John Strotbeck, CEO of Boathouse Sports, discusses results of physical distancing measures at the firm's COVID-adapted factory.
Adam Brufsky, MD: SARS-CoV-2 Attenuation?
Adam Brufsky, MD, PhD, addresses the potential for changing dynamics in SARS-CoV-2.
Contagion Live News Network: Testing for Severe COVID-19
A brief on the latest infectious disease headlines.
Hydroxychloroquine as Postexposure Prophylaxis for COVID-19: Clinical Takeaways
Matthew F. Pullen, MD, co-author of the recent hydroxychloroquine prophylaxis trial, shares the top clinical takeaways.
Putting Remdesivir, Coronavirus Into Perspective
Why people may need to readjust their expectations around COVID-19 clinical data and drugs.
John Strotbeck: How Boathouse Sports Started Making PPE
John Strotbeck, Olympian and CEO of Boathouse Sports, explains how and why the outerwear company pivoted to PPE production at the start of the COVID-19 pandemic.
Contagion Live News Network: The Emerging DRC Ebola Outbreak
A review of the latest infectious disease news.
Reviewing the Pharmacology and Biochemistry of Remdesivir for COVID
Sarah Jorgensen, PharmD, MPH, BCPS, BCIDP, AAHIVP, provides a deep dive on the pharmacology and biochemistry of remdesivir.
Optimizing Remdesivir Use for COVID-19
A look at the means by which clinicians are quantifying and evaluating the effects of the antiviral drug.
Recapping the Remdesivir Rollout
It's been one month since the antiviral therapy was granted emergency use authorization. How has it affected COVID-19 care?
Contagion Live News Network: More Hydroxychloroquine Concerns
A daily infectious disease news update
Kelly Cawcutt, MD: COVID Has "Revolutionized" Health Care
Kelly Cawcutt, MD, MS, shares her thoughts on COVID's impact on health care, as well as why it's so important for clinicians to take breaks.